Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PON-PC-02: ADT Maintenance vs Suspension and Docetaxel Schedule in CRPC
NCT01224405Phase 3Unknown
- Sponsor
- University of Turin
- Start
- Apr 2010
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel in prostate cancer (PCa), sponsored by University of Turin. Status: unknown.
02
Drugs
docetaxel
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01224405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01224405.